These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38117233)

  • 21. Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation.
    Liu J; Jackson K; Weinkauf J; Kapasi A; Hirji A; Meyer S; Mullen J; Nagendran J; Lien D; Halloran K
    J Heart Lung Transplant; 2018 Jul; 37(7):895-902. PubMed ID: 29602706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.
    Porteous MK; Lee JC; Lederer DJ; Palmer SM; Cantu E; Shah RJ; Bellamy SL; Lama VN; Bhorade SM; Crespo MM; McDyer JF; Wille KM; Localio AR; Orens JB; Shah PD; Weinacker AB; Arcasoy S; Wilkes DS; Ware LB; Christie JD; Kawut SM; Diamond JM;
    Ann Am Thorac Soc; 2017 Oct; 14(10):1514-1522. PubMed ID: 28719755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
    Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
    Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated pre-transplant left ventricular end-diastolic pressure increases primary graft dysfunction risk in double lung transplant recipients.
    Li D; Weinkauf J; Hirji A; Kapasi A; Lien D; Nagendran J; Kim D; Ezekowitz J; Halloran K
    J Heart Lung Transplant; 2019 Jul; 38(7):710-718. PubMed ID: 30850154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive function, mental health, and health-related quality of life after lung transplantation.
    Cohen DG; Christie JD; Anderson BJ; Diamond JM; Judy RP; Shah RJ; Cantu E; Bellamy SL; Blumenthal NP; Demissie E; Hopkins RO; Mikkelsen ME
    Ann Am Thorac Soc; 2014 May; 11(4):522-30. PubMed ID: 24605992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients.
    Keller M; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Appl Lab Med; 2022 Jun; 7(4):901-909. PubMed ID: 35024828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A; Saini D; Steward N; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2010 Oct; 90(4):1094-101. PubMed ID: 20868794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study.
    Anderson MR; Udupa JK; Edwin E; Diamond JM; Singer JP; Kukreja J; Hays SR; Greenland JR; Ferrante A; Lippel M; Blue T; McBurnie A; Oyster M; Kalman L; Rushefski M; Wu C; Pednekar G; Liu W; Arcasoy S; Sonett J; D'Ovidio F; Bacchetta M; Newell JD; Torigian D; Cantu E; Farber DL; Giles JT; Tong Y; Palmer S; Ware LB; Hancock WW; Christie JD; Lederer DJ
    J Heart Lung Transplant; 2019 Dec; 38(12):1246-1256. PubMed ID: 31474492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
    Shah RJ; Diamond JM; Lederer DJ; Arcasoy SM; Cantu EM; Demissie EJ; Kawut SM; Kohl B; Lee JC; Sonett J; Christie JD; Ware LB
    Transl Res; 2012 Dec; 160(6):435-42. PubMed ID: 22989614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Including Important Clinical Variables on Accuracy of the Lung Allocation Score for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Lehr CJ; Skeans M; Dasenbrook E; Fink A; Fernandez G; Faro A; Valapour M
    Am J Respir Crit Care Med; 2019 Oct; 200(8):1013-1021. PubMed ID: 31199166
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
    Diamond JM; Kawut SM; Lederer DJ; Ahya VN; Kohl B; Sonett J; Palmer SM; Crespo M; Wille K; Lama VN; Shah PD; Orens J; Bhorade S; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Am J Transplant; 2011 Mar; 11(3):561-7. PubMed ID: 21299834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
    Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
    Lancet Respir Med; 2021 Jun; 9(6):601-612. PubMed ID: 33460570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
    Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
    Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
    Calabrese DR; Ekstrand CA; Yellamilli S; Singer JP; Hays SR; Leard LE; Shah RJ; Venado A; Kolaitis NA; Perez A; Combes A; Greenland JR
    J Heart Lung Transplant; 2024 Jul; 43(7):1074-1086. PubMed ID: 38367738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction.
    Dugger DT; Calabrese DR; Gao Y; Deiter F; Tsao T; Maheshwari J; Hays SR; Leard L; Kleinhenz ME; Shah R; Golden J; Kukreja J; Gordon ED; Singer JP; Greenland JR
    Front Immunol; 2021; 12():704172. PubMed ID: 34691018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical risk factors for primary graft dysfunction after lung transplantation.
    Diamond JM; Lee JC; Kawut SM; Shah RJ; Localio AR; Bellamy SL; Lederer DJ; Cantu E; Kohl BA; Lama VN; Bhorade SM; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Shah AS; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Ware LB; Palmer SM; Christie JD;
    Am J Respir Crit Care Med; 2013 Mar; 187(5):527-34. PubMed ID: 23306540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
    Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
    Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of lung transplantation for chronic obstructive pulmonary disease.
    Türkkan S; Çelik Başaran F; Şahin MF; Beyoğlu MA; Bindal M; Yazıcıoğlu A; Yekeler E
    Tuberk Toraks; 2023 Sep; 71(3):215-223. PubMed ID: 37740625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventilation parameters and early graft function in double lung transplantation.
    Schwarz S; Benazzo A; Dunkler D; Muckenhuber M; Sorbo LD; Di Nardo M; Sinn K; Moser B; Matilla JR; Lang G; Taghavi S; Vamos FR; Jaksch P; Cypel M; Keshavjee S; Klepetko W; Hoetzenecker K
    J Heart Lung Transplant; 2021 Jan; 40(1):4-11. PubMed ID: 33144029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.